Ledyard National Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.92M | Buy |
6,290
+64
| +1% | +$43.6K | 0.31% | 66 |
|
|
2026
Q1 | $4.81M | Buy |
6,226
+93
| +2% | +$71.2K | 0.42% | 51 |
|
|
2025
Q4 | $4.73M | Buy |
6,133
+11
| +0.2% | +$7.47K | 0.41% | 54 |
|
|
2025
Q3 | $3.44M | Sell |
6,122
-243
| -4% | -$137K | 0.31% | 69 |
|
|
2025
Q2 | $3.34M | Buy |
6,365
+120
| +2% | +$67K | 0.32% | 67 |
|
|
2025
Q1 | $3.96M | Sell |
6,245
-280
| -4% | -$193K | 0.39% | 60 |
|
|
2024
Q4 | $4.65M | Buy |
6,525
+134
| +2% | +$112K | 0.44% | 51 |
|
|
2024
Q3 | $6.72M | Sell |
6,391
-190
| -3% | -$211K | 0.61% | 46 |
|
|
2024
Q2 | $6.92M | Sell |
6,581
-400
| -6% | -$388K | 0.67% | 44 |
|
|
2024
Q1 | $6.72M | Sell |
6,981
-454
| -6% | -$432K | 0.65% | 51 |
|
|
2023
Q4 | $6.53M | Sell |
7,435
-198
| -3% | -$163K | 0.67% | 50 |
|
|
2023
Q3 | $6.28M | Sell |
7,633
-120
| -2% | -$94.3K | 0.72% | 50 |
|
|
2023
Q2 | $5.57M | Sell |
7,753
-278
| -3% | -$214K | 0.61% | 53 |
|
|
2023
Q1 | $6.6M | Sell |
8,031
-336
| -4% | -$253K | 0.76% | 48 |
|
|
2022
Q4 | $6.04M | Sell |
8,367
-528
| -6% | -$390K | 0.71% | 52 |
|
|
2022
Q3 | $6.13M | Sell |
8,895
-310
| -3% | -$195K | 0.8% | 43 |
|
|
2022
Q2 | $5.44M | Sell |
9,205
-353
| -4% | -$229K | 0.66% | 59 |
|
|
2022
Q1 | $6.67M | Buy |
9,558
+136
| +1% | +$86K | 0.67% | 57 |
|
|
2021
Q4 | $5.95M | Buy |
9,422
+1,496
| +19% | +$920K | 0.57% | 62 |
|
|
2021
Q3 | $4.8M | Sell |
7,926
-165
| -2% | -$102K | 0.5% | 68 |
|
|
2021
Q2 | $4.52M | Buy |
8,091
+147
| +2% | +$74.5K | 0.46% | 68 |
|
|
2021
Q1 | $3.76M | Buy |
7,944
+372
| +5% | +$181K | 0.4% | 71 |
|
|
2020
Q4 | $3.66M | Buy |
7,572
+5,641
| +292% | +$3.05M | 0.42% | 71 |
|
|
2020
Q3 | $1.08M | Sell |
1,931
-54
| -3% | -$32.7K | 0.14% | 111 |
|
|
2020
Q2 | $1.24M | Sell |
1,985
-56
| -3% | -$31.8K | 0.17% | 108 |
|
|
2020
Q1 | $997K | Sell |
2,041
-87
| -4% | -$35.9K | 0.15% | 120 |
|
|
2019
Q4 | $799K | Sell |
2,128
-4,357
| -67% | -$1.47M | 0.1% | 140 |
|
|
2019
Q3 | $1.8M | Sell |
6,485
-625
| -9% | -$185K | 0.24% | 103 |
|
|
2019
Q2 | $2.23M | Sell |
7,110
-2,453
| -26% | -$817K | 0.3% | 93 |
|
|
2019
Q1 | $3.93M | Buy |
9,563
+9,323
| +3,885% | +$3.84M | 0.52% | 66 |
|
|
2018
Q4 | $90K | Buy |
+240
| New | +$87.8K | 0.01% | 348 |
|
|
2017
Q2 | – | Sell |
-15
| Closed | -$6K | – | 740 |
|
|
2017
Q1 | $6K | Buy |
+15
| New | +$5.56K | ﹤0.01% | 684 |
|
|
2014
Q2 | – | Sell |
-17
| Closed | -$5K | – | 726 |
|
|
2014
Q1 | $5K | Hold |
17
| – | – | ﹤0.01% | 584 |
|
|
2013
Q4 | $5K | Buy |
+17
| New | +$4.89K | ﹤0.01% | 587 |
|
Other funds holding REGN
MCI
Ledyard National Bank's REGN Position: Q2 2026 in Review
Ledyard National Bank increased its Regeneron Pharmaceuticals (REGN) stake by 1% in Q2 2026, buying an estimated $43.6K and bringing the position to 6,290 shares worth $3.92M. The position accounts for 0.31% of the portfolio, ranked #66.
Ledyard National Bank first reported a position in REGN in Q4 2013 and has held it in 34 quarters since. The position peaked at $6.92M in Q2 2024. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Ledyard National Bank held 6,290 shares of Regeneron Pharmaceuticals worth $3.92M as of Q2 2026.
- Ledyard National Bank bought 64 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $43.6K.
- Regeneron Pharmaceuticals made up 0.31% of Ledyard National Bank's portfolio in Q2 2026, its #66 holding.
- Ledyard National Bank first reported a position in Regeneron Pharmaceuticals in Q4 2013 and has held it in 34 quarters since.
- Ledyard National Bank's Regeneron Pharmaceuticals position peaked at $6.92M in Q2 2024.
- 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Ledyard National Bank's 13F filing for Q2 2026, filed 16 Jul 2026.